The Role of Interleukin-I Receptor Antagonist, Anakinra in Critically ILL Adult Patients with Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome, a Review of Six Cases

Puri Akshjot; Kyle Henry J.; Uppalapu Suresh; Raschke Robert

首页> 外文期刊>Pediatric blood & cancer >The Role of Interleukin-I Receptor Antagonist, Anakinra in Critically ILL Adult Patients with Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome, a Review of Six Cases

【24h】

The Role of Interleukin-I Receptor Antagonist, Anakinra in Critically ILL Adult Patients with Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome, a Review of Six Cases

机译：白细胞介素I受体拮抗剂Anakinra在重症ILL合并吞噬细胞性淋巴细胞增多和巨噬细胞活化综合征的成年患者中的作用，六例回顾

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2016年第2期|共2页
作者
Puri Akshjot; Kyle Henry J.; Uppalapu Suresh; Raschke Robert;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. The Role of Interleukin-I Receptor Antagonist, Anakinra in Critically ILL Adult Patients with Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome, a Review of Six Cases [J] . Puri Akshjot, Kyle Henry J., Uppalapu Suresh, Pediatric blood & cancer . 2016,第Suppla2期

机译：白细胞介素I受体拮抗剂Anakinra在重症ILL合并吞噬细胞性淋巴细胞增多和巨噬细胞活化综合征的成年患者中的作用，六例回顾
2. Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis [J] . Wohlfarth Philipp, Agis Hermine, Gualdoni Guido A., Journal of intensive care medicine . 2019,第9期

机译：白细胞介素1受体拮抗剂Anakinra，静脉内免疫球蛋白和皮质类固结剂在危重成年患者的血糖淋巴管菌胞增生症的管理中
3. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU [J] . Cui Yun, Zhang Yu-Cai, Kang Yu-Lin, Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies . 2016,第10期

机译：继发性吞噬细胞淋巴细胞增多/巨噬细胞活化综合征的重症患者的大量血液滤过：PICU的前瞻性研究
4. Coronary Syndrome and Low Molecular Weight Heparin, Glycoprotein Ilb/IHa Receptor Antagonists, Clopidogrel, Urgent Revascularization: Selective Use or Polytherapy for All Patients [C] . International Congress on Coronary Artery Disease . 2003

机译：冠状动脉综合征和低分子量肝素，糖蛋白ILB / IHA受体拮抗剂，氯吡格雷，紧急血运重建：所有患者的选择性使用或聚餐
5. Interventions to prevent the acquisition of resistant Gram-negative bacteria in critically ill patients---A systematic review and meta-analysis. [D] . Zaky, Ahmed. 2012

机译：预防在重症患者中获得耐药性革兰氏阴性菌的干预措施-系统评价和荟萃分析。
6. 7.3 Successful use of anakinra a soluble IL-1 receptor antagonist in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis [O] . PM Miettunen, A Jayanthan, A Narendran 2008

机译：7.3可溶性IL-1受体拮抗剂anakinra在与巨噬细胞活化综合征/反应性吞噬性淋巴细胞组织细胞增生相关的小儿风湿病中的成功应用
7. 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis [O] . Miettunen PM, Jayanthan A, Narendran A 2008

机译：7.3可溶性IL-1受体拮抗剂anakinra在与巨噬细胞活化综合征/反应性吞噬性淋巴细胞组织细胞增生相关的小儿风湿病中的成功应用

The Role of Interleukin-I Receptor Antagonist, Anakinra in Critically ILL Adult Patients with Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome, a Review of Six Cases

著录项

相似文献

相关主题

期刊订阅